<DOC>
	<DOCNO>NCT00886782</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability maximum tolerate dose BMS-863233 subject advance and/or Metastatic solid tumor .</brief_summary>
	<brief_title>A Study BMS-863233 Patients With Advanced and/or Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Phase 1 Subjects advance and/or metastatic solid tumor either refractory relapsed standard therapy , standard therapy exist . ECOG performance status ≤ 2 Accessible treatment , PK sample collection require study followup Total Bilirubin ≤ 1.5 x ULN ALT , AST ≤ 2.5 x ULN Women pregnant breastfeeding Subjects know suspected brain metastasis , primary brain tumor , brain site disease Exposure investigational agent within 4 week study drug administration Subjects history gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Advanced and/or Metastatic solid cancer</keyword>
</DOC>